Marilyn J Hockenberry1, Olga A Taylor2, Alice Pasvogel3, Cheryl Rodgers4, Kathy McCarthy5, Patricia Gundy6, David W Montgomery6, Phillip Ribbeck5, Michael E Scheurer7, Ida M Ki Moore8. 1. School of Nursing, Duke University, Durham, NC. 2. College of Medicine, Baylor University, Houston, TX. 3. College of Nursing, University of Arizona in Tucson. 4. School of Nursing, Duke University. 5. College of Medicine, Baylor University. 6. College of Nursing, University of Arizona. 7. Population Sciences Biorepository, College of Medicine at Baylor University. 8. Biobehavioral Health Science Division in the College of Nursing, University of Arizona.
Abstract
PURPOSE/ OBJECTIVES: To explore the symptom trajectory during the first 16 months of childhood leukemia treatment and any associations with the oxidative stress pathway measured by cerebrospinal fluid (CSF) concentration of oxidized phosphatidylcholine (PC), the predominant glycerophospholipid in the brain and cell membranes. DESIGN: Prospective, longitudinal design. SETTING: Two cancer centers in the southwestern United States. SAMPLE: 36 children (aged 3-14 years) newly diagnosed with acute lymphoblastic leukemia. METHODS: Symptoms were measured using the Memorial Symptom Assessment Scale at six specific time points during treatment. Biochemical changes in oxidative stress were measured by oxidized PC in the CSF. MAIN RESEARCH VARIABLES: Childhood cancer symptoms, oxidized PC. FINDINGS: Significant differences were found in the number of symptoms experienced during the three phases of treatment. Symptom trajectory changes and influence of the oxidative stress pathway on symptom experiences were identified. CONCLUSIONS: Symptoms experienced during treatment for childhood leukemia are associated with increased oxidative stress. IMPLICATIONS FOR NURSING: Children with leukemia experience symptoms throughout treatment. Physiologic measures indicate the influence of oxidative stress on symptoms.
PURPOSE/ OBJECTIVES: To explore the symptom trajectory during the first 16 months of childhood leukemia treatment and any associations with the oxidative stress pathway measured by cerebrospinal fluid (CSF) concentration of oxidized phosphatidylcholine (PC), the predominant glycerophospholipid in the brain and cell membranes. DESIGN: Prospective, longitudinal design. SETTING: Two cancer centers in the southwestern United States. SAMPLE: 36 children (aged 3-14 years) newly diagnosed with acute lymphoblastic leukemia. METHODS: Symptoms were measured using the Memorial Symptom Assessment Scale at six specific time points during treatment. Biochemical changes in oxidative stress were measured by oxidized PC in the CSF. MAIN RESEARCH VARIABLES: Childhood cancer symptoms, oxidized PC. FINDINGS: Significant differences were found in the number of symptoms experienced during the three phases of treatment. Symptom trajectory changes and influence of the oxidative stress pathway on symptom experiences were identified. CONCLUSIONS: Symptoms experienced during treatment for childhood leukemia are associated with increased oxidative stress. IMPLICATIONS FOR NURSING: Children with leukemia experience symptoms throughout treatment. Physiologic measures indicate the influence of oxidative stress on symptoms.
Authors: Lois Van Cleve; Cynthia E Muñoz; Marilyn Savedra; Matt Riggs; Elizabeth Bossert; Marcia Grant; Kathleen Adlard Journal: Cancer Nurs Date: 2012 Mar-Apr Impact factor: 2.592
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: G Sener; E Ekşioğlu-Demiralp; M Cetiner; F Ercan; S Sirvanci; N Gedik; B C Yeğen Journal: Cell Biol Toxicol Date: 2006-01 Impact factor: 6.691
Authors: Marilyn J Hockenberry; Mary C Hooke; Maryann Gregurich; Kathy McCarthy; Gennaro Sambuco; Kevin Krull Journal: Oncol Nurs Forum Date: 2010-01 Impact factor: 2.172
Authors: Cheryl Rodgers; Chelse Sanborn; Olga Taylor; Patricia Gundy; Alice Pasvogel; Ida M Ki Moore; Marilyn J Hockenberry Journal: Biol Res Nurs Date: 2016-05-13 Impact factor: 2.522
Authors: Ida M Ki Moore; Patricia Gundy; Alice Pasvogel; David W Montgomery; Olga A Taylor; Kari M Koerner; Kathy McCarthy; Marilyn J Hockenberry Journal: J Pediatr Hematol Oncol Date: 2015-03 Impact factor: 1.289
Authors: Mary C Hooke; Michelle A Mathiason; Audrey Blommer; Jessica Hutter; Pauline Mitby; Olga Taylor; Michael E Scheurer; Alicia S Kunin-Batson; Wei Pan; Marilyn J Hockenberry Journal: Cancer Nurs Date: 2022 Mar-Apr 01 Impact factor: 2.592
Authors: Austin L Brown; Kimberly P Raghubar; Olga A Taylor; Melanie Brooke Bernhardt; Lisa S Kahalley; Wei Pan; Philip J Lupo; Marilyn J Hockenberry; Michael E Scheurer Journal: Support Care Cancer Date: 2020-09-14 Impact factor: 3.603
Authors: Austin L Brown; Pagna Sok; Olga Taylor; John P Woodhouse; M Brooke Bernhardt; Kimberly P Raghubar; Lisa S Kahalley; Philip J Lupo; Marilyn J Hockenberry; Michael E Scheurer Journal: J Pain Symptom Manage Date: 2020-09-01 Impact factor: 3.612
Authors: Lauri A Linder; Amy R Newman; Kristin Stegenga; Yin-Shun Chiu; Sarah E Wawrzynski; Heidi Kramer; Charlene Weir; Scott Narus; Roger Altizer Journal: Support Care Cancer Date: 2020-05-02 Impact factor: 3.603